000963 华东医药
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额2,499,4204,245,6043,748,9293,929,2172,381,853
投资活动产生之现金流量净额(762,607)(1,669,772)(2,170,272)(1,750,552)(2,435,598)
筹资活动产生之现金流量净额(983,957)(2,822,472)(749,664)(1,393,361)(99,710)
汇率变动对现金及现金等价物的影响(1,459)(7,590)(47,002)5,946(9,775)
现金及现金等价物净增加/(减少)751,397(254,230)781,991791,249(163,230)
期初现金及现金等价物余额4,735,9224,990,1514,208,1603,416,9113,580,141
期末现金及现金等价物余额5,487,3194,735,9224,990,1514,208,1603,416,911